We are live on
!
Find out more
SG Americas Securities Portfolio holdings
AUM
$92.9B
1-Year Est. Return
36.98%
This Fund
S&P 500
This Quarter
Est. Return
-6.3%
1 Year Est. Return
+36.98%
3 Year Est. Return
+96.33%
5 Year Est. Return
+110.18%
10 Year Est. Return
+436.29%
AUM
$30.5B
AUM Growth
+$6.11B
(+25%)
Cap. Flow
+$9.67B
Cap. Flow
% of AUM
31.72%
Top 10 Holdings %
Top 10 Hldgs %
46.6%
Holding
3,856
New
751
Increased
1,330
Reduced
1,206
Closed
418
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.46B |
| 2 |
Apple
AAPL
|
+$507M |
| 3 |
NVIDIA
NVDA
|
+$470M |
| 4 |
Meta Platforms (Facebook)
META
|
+$404M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$409M |
| 2 |
Broadcom
AVGO
|
+$292M |
| 3 |
Oracle
ORCL
|
+$111M |
| 4 |
Microsoft
MSFT
|
+$109M |
| 5 |
Intuit
INTU
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.72% |
| 2 | Communication Services | 17.72% |
| 3 | Healthcare | 7.71% |
| 4 | Financials | 7.66% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Black Diamond Therapeutics
BDTX
$102M
| $24K | ﹤0.01% |
15,315
-4,176
| -21% | -$8.76K |
|
3277
BRC Inc
BRCC
$124M
| $24K | ﹤0.01% |
11,647
-6,512
| -36% | -$16.6K |
|
3278
CALL
Las Vegas Sands
LVS
$29.7B
| $24K | ﹤0.01% |
123,200
| – | – |
|
3279
PUT
Marathon Digital Holdings
MARA
$4.48B
| $23K | ﹤0.01% |
493,700
-840,900
| -63% | -$13.4M |
|
3280
Energy Vault
NRGV
$596M
| $23K | ﹤0.01% |
33,702
-9,898
| -23% | -$15.2K |
|
3281
ProKidney
PROK
$332M
| $23K | ﹤0.01% |
+26,528
| New | +$36.8K |
|
3282
Tango Therapeutics
TNGX
$4.72B
| $23K | ﹤0.01% |
17,029
-4,934
| -22% | -$12.1K |
|
|
AGEN
3283
Agenus
AGEN
$337M
| $22K | ﹤0.01% |
+14,485
| New | +$41.7K |
|
|
FRGE
3284
DELISTED
Forge Global Holdings
FRGE
| $22K | ﹤0.01% |
2,572
-1,785
| -41% | -$20.6K |
|
3285
GrowGeneration
GRWG
$90.1M
| $22K | ﹤0.01% |
20,400
-3,043
| -13% | -$4.08K |
|
3286
Nautilus Biotechnolgy
NAUT
$129M
| $22K | ﹤0.01% |
26,034
-1,449
| -5% | -$2.15K |
|
|
NOTE
3287
DELISTED
FiscalNote
NOTE
| $22K | ﹤0.01% |
2,257
+150
| +7% | +$2.26K |
|
3288
Purple Innovation
PRPL
$42.9M
| $22K | ﹤0.01% |
1,152
-259
| -18% | -$5.97K |
|
3289
X4 Pharmaceuticals
XFOR
$397M
| $22K | ﹤0.01% |
3,050
-3,055
| -50% | -$42.1K |
|
3290
Aemetis
AMTX
$112M
| $21K | ﹤0.01% |
12,228
-20,217
| -62% | -$43.2K |
|
|
KG
3291
Kestrel Group
KG
$77.8M
| $21K | ﹤0.01% |
1,824
-481
| -21% | -$9.07K |
|
3292
Shattuck Labs
STTK
$718M
| $21K | ﹤0.01% |
22,200
-9,852
| -31% | -$12.1K |
|
3293
Acumen Pharmaceuticals
ABOS
$160M
| $20K | ﹤0.01% |
18,007
-7,624
| -30% | -$10.9K |
|
3294
PUT
Palantir
PLTR
$390B
| $20K | ﹤0.01% |
62,300
-201,500
| -76% | -$17.7M |
|
|
LNAI
3295
Lunai Bioworks
LNAI
$10.9M
| $20K | ﹤0.01% |
464
-183
| -28% | -$11.7K |
|
3296
PUT
Intercontinental Exchange
ICE
$83.3B
| $19K | ﹤0.01% |
26,200
| – | – |
|
3297
Inovio Pharmaceuticals
INO
$70.2M
| $19K | ﹤0.01% |
11,778
+958
| +9% | +$1.92K |
|
3298
LiveOne
LVO
$61.6M
| $19K | ﹤0.01% |
2,736
-657
| -19% | -$6.47K |
|
3299
Stem
STEM
$53.6M
| $19K | ﹤0.01% |
2,739
-375
| -12% | -$4.34K |
|
3300
TScan Therapeutics
TCRX
$47.8M
| $19K | ﹤0.01% |
13,581
-6,834
| -33% | -$14.8K |
|
Similar funds
SG Americas Securities's Q1 2025 Portfolio in Review
As of Q1 2025, SG Americas Securities held 3,856 positions worth $30.5B, up 25% from $24.4B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
SG Americas Securities deployed $9.67B of net new capital in Q1 2025, opening 751 new positions and adding to 1,330 existing holdings. Its largest new stake was Biogen: 719,793 shares worth $98.5M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 40% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $409M trimmed.
- SG Americas Securities's largest Q1 2025 buy was Biogen: 719,793 shares worth $98.5M.
- SG Americas Securities added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $1.46B increase.
- SG Americas Securities's biggest Q1 2025 reduction was Alphabet (Google) Class A, cutting an estimated $409M.
- SG Americas Securities fully exited iShares Ethereum Trust ETF in Q1 2025, selling an estimated $49.8M.
- SG Americas Securities's ten largest holdings make up 47% of its $30.5B portfolio in Q1 2025.
- SG Americas Securities opened 751 new positions and closed 418 in Q1 2025.
- SG Americas Securities's portfolio value rose 25% quarter-over-quarter to $30.5B.
Based on SG Americas Securities's 13F filing for Q1 2025, filed 15 Apr 2025.